฿3.6 billion approved for COVID-19 vaccine development

13 Sept 17:41 Key points summarised by AI

The Thai cabinet approved ฿3.6 billion to accelerate the development and production of two homegrown COVID-19 vaccines: ChulaCov19 (mRNA) and Baiya (plant-based).
Both vaccines are currently in Phase 3 human trials, with registration targeted for mid-next year to enable commercial production.
Developing local vaccines is crucial for Thailand to effectively combat future coronavirus mutations and bolster national health security.

Uthenthawai students and alumni declare truce with Pathumwan rivals

Yesterday 20:34 Key points summarised by AI

Uthenthawai students and alumni have pledged to cease violent clashes with Pathumwan Institute rivals, coinciding with their campus's reopening after a 90-day closure.
The Minister of Higher Education is mediating the long-running conflict, while the campus closure has significantly disrupted in-person classes and laboratory work for over 1,000 students.
Uthenthawai resists relocation from its current site, citing a historical land grant from King Rama VI, despite Chulalongkorn University's plans to reclaim the land for an educational hub.
Concerns are mounting over the legality of the campus closure, its detrimental impact on uninvolved students, and the potential commercial development of the land, which critics argue contradicts the late King Rama VI's intentions.